nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Alfentanil—ALB—chronic obstructive pulmonary disease	0.00496	0.433	CrCbGaD
Remifentanil—Pethidine—SLC6A4—chronic obstructive pulmonary disease	0.00425	0.371	CrCbGaD
Remifentanil—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00238	0.00241	CcSEcCtD
Remifentanil—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00239	CcSEcCtD
Remifentanil—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00239	CcSEcCtD
Remifentanil—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00239	CcSEcCtD
Remifentanil—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00239	CcSEcCtD
Remifentanil—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00238	CcSEcCtD
Remifentanil—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.00237	CcSEcCtD
Remifentanil—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00234	0.00237	CcSEcCtD
Remifentanil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00233	0.00236	CcSEcCtD
Remifentanil—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00232	0.00234	CcSEcCtD
Remifentanil—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00231	0.00234	CcSEcCtD
Remifentanil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00231	0.00234	CcSEcCtD
Remifentanil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00231	0.00233	CcSEcCtD
Remifentanil—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.00233	CcSEcCtD
Remifentanil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0023	0.00232	CcSEcCtD
Remifentanil—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00232	CcSEcCtD
Remifentanil—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00232	CcSEcCtD
Remifentanil—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00228	0.00231	CcSEcCtD
Remifentanil—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.00229	CcSEcCtD
Remifentanil—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00226	0.00229	CcSEcCtD
Remifentanil—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00225	0.00227	CcSEcCtD
Remifentanil—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00227	CcSEcCtD
Remifentanil—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00224	0.00226	CcSEcCtD
Remifentanil—Pethidine—ALB—chronic obstructive pulmonary disease	0.00223	0.195	CrCbGaD
Remifentanil—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00226	CcSEcCtD
Remifentanil—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00225	CcSEcCtD
Remifentanil—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00224	CcSEcCtD
Remifentanil—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00223	CcSEcCtD
Remifentanil—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00218	0.00221	CcSEcCtD
Remifentanil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00218	0.0022	CcSEcCtD
Remifentanil—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00216	0.00219	CcSEcCtD
Remifentanil—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00215	0.00218	CcSEcCtD
Remifentanil—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00216	CcSEcCtD
Remifentanil—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00216	CcSEcCtD
Remifentanil—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00209	0.00212	CcSEcCtD
Remifentanil—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00209	0.00212	CcSEcCtD
Remifentanil—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00211	CcSEcCtD
Remifentanil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00207	0.00209	CcSEcCtD
Remifentanil—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00207	CcSEcCtD
Remifentanil—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00205	0.00207	CcSEcCtD
Remifentanil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00203	0.00205	CcSEcCtD
Remifentanil—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00204	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00199	0.00201	CcSEcCtD
Remifentanil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00199	0.00201	CcSEcCtD
Remifentanil—Cough—Formoterol—chronic obstructive pulmonary disease	0.00199	0.00201	CcSEcCtD
Remifentanil—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.002	CcSEcCtD
Remifentanil—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00197	0.00199	CcSEcCtD
Remifentanil—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00197	0.00199	CcSEcCtD
Remifentanil—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.00199	CcSEcCtD
Remifentanil—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00195	0.00197	CcSEcCtD
Remifentanil—Cough—Montelukast—chronic obstructive pulmonary disease	0.00195	0.00197	CcSEcCtD
Remifentanil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00194	0.00196	CcSEcCtD
Remifentanil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00196	CcSEcCtD
Remifentanil—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00196	CcSEcCtD
Remifentanil—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00196	CcSEcCtD
Remifentanil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00193	0.00195	CcSEcCtD
Remifentanil—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00195	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00195	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00195	CcSEcCtD
Remifentanil—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00192	CcSEcCtD
Remifentanil—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00192	CcSEcCtD
Remifentanil—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00192	CcSEcCtD
Remifentanil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00191	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00191	CcSEcCtD
Remifentanil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.0019	CcSEcCtD
Remifentanil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00188	CcSEcCtD
Remifentanil—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00188	CcSEcCtD
Remifentanil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00188	CcSEcCtD
Remifentanil—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00188	CcSEcCtD
Remifentanil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00188	CcSEcCtD
Remifentanil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00183	0.00185	CcSEcCtD
Remifentanil—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00185	CcSEcCtD
Remifentanil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00185	CcSEcCtD
Remifentanil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.00184	CcSEcCtD
Remifentanil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00182	0.00184	CcSEcCtD
Remifentanil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00184	CcSEcCtD
Remifentanil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00184	CcSEcCtD
Remifentanil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00184	CcSEcCtD
Remifentanil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00184	CcSEcCtD
Remifentanil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00183	CcSEcCtD
Remifentanil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00183	CcSEcCtD
Remifentanil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.00182	CcSEcCtD
Remifentanil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00181	CcSEcCtD
Remifentanil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00179	0.00181	CcSEcCtD
Remifentanil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00178	0.0018	CcSEcCtD
Remifentanil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00179	CcSEcCtD
Remifentanil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00178	CcSEcCtD
Remifentanil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00178	CcSEcCtD
Remifentanil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00174	0.00176	CcSEcCtD
Remifentanil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.00176	CcSEcCtD
Remifentanil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00175	CcSEcCtD
Remifentanil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00175	CcSEcCtD
Remifentanil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00174	CcSEcCtD
Remifentanil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00173	CcSEcCtD
Remifentanil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00173	CcSEcCtD
Remifentanil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00172	CcSEcCtD
Remifentanil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00172	CcSEcCtD
Remifentanil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00167	0.00169	CcSEcCtD
Remifentanil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00168	CcSEcCtD
Remifentanil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00168	CcSEcCtD
Remifentanil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00167	CcSEcCtD
Remifentanil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00167	CcSEcCtD
Remifentanil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00166	CcSEcCtD
Remifentanil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00166	CcSEcCtD
Remifentanil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00166	CcSEcCtD
Remifentanil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00165	CcSEcCtD
Remifentanil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00165	CcSEcCtD
Remifentanil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00164	CcSEcCtD
Remifentanil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00162	0.00163	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00162	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00162	CcSEcCtD
Remifentanil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00162	CcSEcCtD
Remifentanil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00161	CcSEcCtD
Remifentanil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00161	CcSEcCtD
Remifentanil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00161	CcSEcCtD
Remifentanil—Pain—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00161	CcSEcCtD
Remifentanil—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00158	0.0016	CcSEcCtD
Remifentanil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00159	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00159	CcSEcCtD
Remifentanil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00158	CcSEcCtD
Remifentanil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00158	CcSEcCtD
Remifentanil—Pain—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00158	CcSEcCtD
Remifentanil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00155	0.00157	CcSEcCtD
Remifentanil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00156	CcSEcCtD
Remifentanil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00156	CcSEcCtD
Remifentanil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00156	CcSEcCtD
Remifentanil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00155	CcSEcCtD
Remifentanil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00155	CcSEcCtD
Remifentanil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.00155	CcSEcCtD
Remifentanil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00154	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00153	CcSEcCtD
Remifentanil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00152	CcSEcCtD
Remifentanil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00152	CcSEcCtD
Remifentanil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00149	CcSEcCtD
Remifentanil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00149	CcSEcCtD
Remifentanil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00149	CcSEcCtD
Remifentanil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00149	CcSEcCtD
Remifentanil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Remifentanil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Remifentanil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Remifentanil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Remifentanil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00146	CcSEcCtD
Remifentanil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00146	CcSEcCtD
Remifentanil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00146	CcSEcCtD
Remifentanil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00146	CcSEcCtD
Remifentanil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00146	CcSEcCtD
Remifentanil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00144	CcSEcCtD
Remifentanil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00143	CcSEcCtD
Remifentanil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00143	CcSEcCtD
Remifentanil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00141	CcSEcCtD
Remifentanil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.0014	CcSEcCtD
Remifentanil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00139	CcSEcCtD
Remifentanil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00139	CcSEcCtD
Remifentanil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.00138	CcSEcCtD
Remifentanil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00137	0.00138	CcSEcCtD
Remifentanil—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00137	CcSEcCtD
Remifentanil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00136	CcSEcCtD
Remifentanil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Remifentanil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Remifentanil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00131	CcSEcCtD
Remifentanil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00129	0.0013	CcSEcCtD
Remifentanil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00129	CcSEcCtD
Remifentanil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00129	CcSEcCtD
Remifentanil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00128	CcSEcCtD
Remifentanil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00126	CcSEcCtD
Remifentanil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00126	CcSEcCtD
Remifentanil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00125	CcSEcCtD
Remifentanil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00124	CcSEcCtD
Remifentanil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00124	CcSEcCtD
Remifentanil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00122	CcSEcCtD
Remifentanil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00122	CcSEcCtD
Remifentanil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00118	0.0012	CcSEcCtD
Remifentanil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.0012	CcSEcCtD
Remifentanil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00119	CcSEcCtD
Remifentanil—Rash—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00119	CcSEcCtD
Remifentanil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00118	CcSEcCtD
Remifentanil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00118	CcSEcCtD
Remifentanil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Remifentanil—Headache—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Remifentanil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00117	CcSEcCtD
Remifentanil—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00117	CcSEcCtD
Remifentanil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00117	CcSEcCtD
Remifentanil—Rash—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00116	CcSEcCtD
Remifentanil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00116	CcSEcCtD
Remifentanil—Headache—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00115	CcSEcCtD
Remifentanil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00113	CcSEcCtD
Remifentanil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00112	CcSEcCtD
Remifentanil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00112	CcSEcCtD
Remifentanil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00112	CcSEcCtD
Remifentanil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00112	CcSEcCtD
Remifentanil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00112	CcSEcCtD
Remifentanil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.0011	CcSEcCtD
Remifentanil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00109	CcSEcCtD
Remifentanil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00108	CcSEcCtD
Remifentanil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00108	CcSEcCtD
Remifentanil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00106	CcSEcCtD
Remifentanil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00105	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00105	CcSEcCtD
Remifentanil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00104	CcSEcCtD
Remifentanil—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00104	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Remifentanil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Remifentanil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000991	0.001	CcSEcCtD
Remifentanil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000983	0.000994	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000973	0.000985	CcSEcCtD
Remifentanil—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000956	0.000967	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000934	0.000945	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00093	0.000941	CcSEcCtD
Remifentanil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00092	0.000931	CcSEcCtD
Remifentanil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000904	0.000915	CcSEcCtD
Remifentanil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000897	0.000907	CcSEcCtD
Remifentanil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000861	0.000871	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00083	0.000839	CcSEcCtD
Remifentanil—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000829	0.000838	CcSEcCtD
Remifentanil—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000824	0.000833	CcSEcCtD
Remifentanil—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000804	0.000813	CcSEcCtD
Remifentanil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.0008	0.000809	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000788	0.000797	CcSEcCtD
Remifentanil—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000777	0.000786	CcSEcCtD
Remifentanil—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000774	0.000783	CcSEcCtD
Remifentanil—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000761	0.000769	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000758	0.000767	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000742	0.00075	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000732	0.00074	CcSEcCtD
Remifentanil—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000732	0.00074	CcSEcCtD
Remifentanil—Shock—Prednisone—chronic obstructive pulmonary disease	0.00072	0.000728	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000718	0.000726	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000714	0.000722	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000711	0.000719	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000707	0.000716	CcSEcCtD
Remifentanil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000666	0.000674	CcSEcCtD
Remifentanil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000657	0.000665	CcSEcCtD
Remifentanil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000644	0.000652	CcSEcCtD
Remifentanil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000635	0.000642	CcSEcCtD
Remifentanil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000634	0.000642	CcSEcCtD
Remifentanil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000631	0.000638	CcSEcCtD
Remifentanil—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000626	0.000633	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000603	0.00061	CcSEcCtD
Remifentanil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000598	0.000605	CcSEcCtD
Remifentanil—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000581	0.000588	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000578	0.000585	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000539	0.000545	CcSEcCtD
Remifentanil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000518	0.000524	CcSEcCtD
Remifentanil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000501	0.000506	CcSEcCtD
Remifentanil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000484	0.000489	CcSEcCtD
Remifentanil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000465	0.000471	CcSEcCtD
Remifentanil—Rash—Prednisone—chronic obstructive pulmonary disease	0.000461	0.000467	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000461	0.000466	CcSEcCtD
Remifentanil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000458	0.000464	CcSEcCtD
Remifentanil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000435	0.00044	CcSEcCtD
